반응식
[CH2:1]([C:3]1[N:4]([C:14]2[CH:19]=[CH:18][C:17]([CH2:20][CH2:21][NH:22][C:23](=O)[O-:24])=[CH:16][CH:15]=2)[CH:5]=[C:6]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)[N:7]=1)[CH3:2].[Cl:26][C:27]1[CH:32]=[CH:31][C:30]([S:33]([NH2:36])(=[O:35])=[O:34])=[CH:29][CH:28]=1>>[Cl:26][C:27]1[CH:28]=[CH:29][C:30]([S:33]([NH:36][C:23]([NH:22][CH2:21][CH2:20][C:17]2[CH:16]=[CH:15][C:14]([N:4]3[CH:5]=[C:6]([C:8]4[CH:9]=[CH:10][CH:11]=[CH:12][CH:13]=4)[N:7]=[C:3]3[CH2:1][CH3:2])=[CH:19][CH:18]=2)=[O:24])(=[O:34])=[O:35])=[CH:31][CH:32]=1참가 물질
3
실험 절차
The title compound was prepared according to the procedure described in step 2 of Example 18 from 2-[4-(2-ethyl-4-phenyl-1H-imidazol-1-yl)phenyl]ethylcarbamate and 4-chlorobenzenesulfonamide. MS (ESI) m/z 509 [M+H]+, 507 [M−H]−, 1H-NMR (DMSO-d6) δ 1.14 (3H, t, J=7.5 Hz), 2.62 (2H, q, J=7.5 Hz), 2.72 (2H, t, J=7.1 Hz), 3.18-3.30 (2H, m), 6.60 (1H, t, J=5.7 Hz), 7.19 (1H, tt, J=7.3, 1.3 Hz), 7.28-7.38 (6H, m), 7.64-7.70 (2H, m), 7.76-7.80 (2H, m), 7.88 (2H, dt, J=11.2, 2.6 Hz).
출처 및 근거
- ORD 기록
- ord-bd6ea95aca4049e588eefbb023a216b3
- 출처 데이터셋
- uspto-grants-2005_10
- 특허 번호
- US06956050B2
연결된 노트
불러오는 중…